Trevor  Bezdek net worth and biography

Trevor Bezdek Biography and Net Worth

Co-founder & Chairman of GoodRx
Trevor is on a mission to lower the cost of prescriptions in America. Before co-founding GoodRx, Trevor created Tryarc, a technology company delivering strategy and implementation services for healthcare and media organizations. Tryarc became one of the largest private IT services in California, doing business with Anthem/Blue Cross, Toyota and Sony, among others.

In 2007, Trevor sold the company to NTT, where he received the President’s Award for leadership. Previously, Trevor co-founded Biowire, a community for biologists and other scientists to share insights on best practices and resources.

Trevor is an engaged member of his community, serving on the Board of Trustees of Crossroads School for Arts & Sciences and as a member of Young Presidents’ Organization (YPO). Trevor graduated with honors from Stanford University with degrees in biological sciences and computer science.

How old is Trevor Bezdek?

Mr. Bezdek is currently 46 years old. There are 6 older executives and no younger executives at GoodRx. The oldest executive at GoodRx is Mr. Karsten Ian Voermann, CFO & Principal Financial Officer, who is 54 years old. Learn More on Trevor Bezdek's age.

How do I contact Trevor Bezdek?

The corporate mailing address for Mr. Bezdek and other GoodRx executives is 233 WILSHIRE BLVD. SUITE 990, SANTA MONICA CA, 90401. GoodRx can also be reached via phone at 855-268-2822 and via email at [email protected]. Learn More on Trevor Bezdek's contact information.

Has Trevor Bezdek been buying or selling shares of GoodRx?

Trevor Bezdek has not been actively trading shares of GoodRx within the last three months. Most recently, Trevor Bezdek sold 64,271 shares of the business's stock in a transaction on Wednesday, December 22nd. The shares were sold at an average price of $35.19, for a transaction totalling $2,261,696.49. Learn More on Trevor Bezdek's trading history.

Who are GoodRx's active insiders?

GoodRx's insider roster includes Babak Azad (Insider), Trevor Bezdek (Co-founder & Chairman), Douglas Hirsch (CEO), Bansi Nagji (Insider), Agnes Rey-Giraud (Director), Andrew Slutsky (Insider), Karsten Voermann (CFO), and Scott Wagner (Insider). Learn More on GoodRx's active insiders.

Are insiders buying or selling shares of GoodRx?

During the last twelve months, insiders at the sold shares 1 times. They sold a total of 10,677 shares worth more than $83,921.22. The most recent insider tranaction occured on September, 3rd when Major Shareholder Equity Vii L.P. Spectrum sold 10,677 shares worth more than $83,921.22. Insiders at GoodRx own 4.2% of the company. Learn More about insider trades at GoodRx.

Information on this page was last updated on 9/3/2024.

Trevor Bezdek Insider Trading History at GoodRx

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/22/2021Sell64,271$35.19$2,261,696.49View SEC Filing Icon  
See Full Table

Trevor Bezdek Buying and Selling Activity at GoodRx

This chart shows Trevor Bezdek's buying and selling at GoodRx by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

GoodRx Company Overview

GoodRx logo
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.
Read More

Today's Range

Now: $4.52
Low: $4.37
High: $4.53

50 Day Range

MA: $5.33
Low: $4.15
High: $6.96

2 Week Range

Now: $4.52
Low: $4.09
High: $9.26

Volume

964,600 shs

Average Volume

1,427,372 shs

Market Capitalization

$1.72 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.29